# FDA Inspection 1266962 - Klatsky, Peter Charles MD Inc - March 19, 2025

Source: https://www.keypedia.com/records/fda_inspections/klatsky-peter-charles-md-inc/028440e3-1e61-4a81-b042-38c7d42ad94c
Source feed: FDA_Inspections

> FDA Inspection 1266962 for Klatsky, Peter Charles MD Inc on March 19, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266962
- Company Name: Klatsky, Peter Charles MD Inc
- Inspection Date: 2025-03-19
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1266962 - 2025-03-19](https://www.keypedia.com/records/fda_inspections/klatsky-peter-charles-md-inc/bf4ba4e0-725d-44d7-afb8-22df55b3c76f)
- [FDA Inspection 1071925 - 2018-10-15](https://www.keypedia.com/records/fda_inspections/klatsky-peter-charles-md-inc/9a76f402-88df-4b69-a65d-469310cffeee)
- [FDA Inspection 1071925 - 2018-10-15](https://www.keypedia.com/records/fda_inspections/klatsky-peter-charles-md-inc/b03fb425-d380-4a62-a4fa-47cbc0c5489e)

Company: https://www.keypedia.com/companies/klatsky-peter-charles-md-inc/e83ad75d-ebad-457c-9465-5dc863bd0f50

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d